Antiadrenergic therapy of chronic heart failure - Surprises and new opportunities

被引：70

作者：

Bristow, M ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA

来源：

关键词：

heart failure; nervous system sympathetic; receptors; adrenergic; alpha; beta;

D O I：

10.1161/01.CIR.0000054530.87613.36

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1100 / 1102

页数：3

共 25 条

[1] Bucindolol displays intrinsic sympathomimetic activity in human myocardium
Andreka, P
Aiyar, N
Olson, LC
Wei, JQ
Turner, MS
Webster, KA
Ohlstein, EH
Bishopric, NH
[J]. CIRCULATION, 2002, 105 (20) : 2429 - 2434
[2] Braunwald E, 2000, CIRCULATION, V102, P14
[3] β-adrenergic receptor blockade in chronic heart failure
Bristow, MR
[J]. CIRCULATION, 2000, 101 (05) : 558 - 569
[4] Bristow MR, 2000, CIRCULATION, V102, P484
[5] Inotropes and β-blockers:: Is there a need for new guidelines?
Bristow, MR
Shakar, SF
Linseman, JV
Lowes, BD
[J]. JOURNAL OF CARDIAC FAILURE, 2001, 7 (02) : 8 - 12
[6] Bristow MR, 2001, CIRCULATION, V104, P755
[7] BRISTOW MR, 1998, CLIN CARDIOLOGY S1, V21
[8] Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium
Brixius, K
Bundkirchen, A
Bölck, B
Mehlhorn, U
Schwinger, RHG
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (08) : 1330 - 1338
[9] Heart failure 99 - the Moxcon story
Coats, AJS
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 71 (02) : 109 - 111
[10] DOMANSKI MJ, 2001, J CARDIAC FAILURE S3, V7, P56